Protean’s battery achieves ‘in use’ performance milestone


Published 12-JUN-2018 11:14 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Protean Energy Ltd (ASX:POW) has provided an update regarding the extensive testing program carried out on its 5kW and 25kW V-KOR vanadium battery units.

Over 3,000 cycles have now been tested on the 5kW stack, representing in excess of nine years of full daily cycles for a typical solar photovoltaic (PV) application. In addition, more than 1,000 cycles (three years of full daily cycles) of testing has been completed on the 25kW stack.

Crucially, both units reported no significant degradation in performance. The completion of this successful testing is considered to be representative of “in use” battery performance and therefore, is a key step in POW’s progression towards the commercialisation of V-KOR and customer orders.

Both V-KOR units were independently tested by Korea Conformity Laboratories (KCL), a leading state-of-the-art national testing laboratory established over 40 years ago.

The proprietary V-KOR technology is 100% owned by KORID Energy (KORID), a 50% owned subsidiary of POW devoted to developing battery technology.

The V-KOR technology — which has been developed over the last five years with over US$3 million dollars invested to date in research, development, testing and IP protection — is underpinned by 15 granted patents.

20kW solar PV integrated with two 25kW V-KOR battery and the electricity grid in a field test site at Seosan-si in Korea.

However, POW remains a speculative play and there is much work to be done, so investors should seek professional financial advice if considering this stock for their portfolio.

About KORID and V-KOR

KORID is jointly owned by Protean (50%) and KOSDAQ-listed DST Company Limited (50%).

KORID has utilised grant funding over the last five years to develop four stack sizes of flow batteries, including 2.5kW, 5kW, 10kW and 25kW units to provide commercial options to customers with varying energy consumption and storage needs.

Ultimately, the end-result of V-KOR’s strategy is to provide large (1-5MW) storage units with energy storage capacity expanded simply by increasing electrolyte volume.

In addition to KORID’s current Australian trial, two 25kW stacks are undergoing field trials with KCL as part of a solar PV and VRFB-ESS combination trial in Korea.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free